4 ms·

I have no clue where most drug research or drug development takes place. Right now the discussion tends to end up with US companies saying they charge so much f

I have no clue where most drug research or drug development takes place. Right now the discussion tends to end up with US companies saying they charge so much for new medications to recoup the costs of ideas that didn’t pan out. Since only the drug companies know what didn’t pan out, it’s hard to refute. If most drug research happens in the US (and, really, I don’t know if that’s true), then it suggests that the US model does a good job of incentivizing research. If another approach could get the same results, it would refute the drug companies’ argument.

lotsofpulp 2y ago
> Right now the discussion tends to end up with US companies saying they charge so much for new medications to recoup the costs of ideas that didn’t pan out. This is just public relations, because “we want to make as much money as possible” is not good PR. However, everyone wants to make as much money as possible, so faulting pharmaceutical companies for that is stupid. It’s just business. > Since only the drug companies know what didn’t pan out, it’s hard to refute. Lots of pharmaceutical businesses don’t pan out. For every Novo Nordisk, there are a lot of upstart pharma companies that go nowhere and lots of gambling day traders that lose money on the stock. Otherwise, an index of purely pharma companies would be the best performing asset class. > If most drug research happens in the US (and, really, I don’t know if that’s true), then it suggests that the US model does a good job of incentivizing research. If another approach could get the same results, it would refute the drug companies’ argument. Exactly! If it’s so easy to develop medicines, then do it. All these governments around the world are free to invest tens of billions of dollars, and yet none take up the cause.
- Jensson 2y ago
  > All these governments around the world are free to invest tens of billions of dollars, and yet none take up the cause. It is only expensive in USA, why would anyone else pay to make it cheaper in USA? Until USA changes there is no incentive for anyone else to pay for it. And a very large share of drug research is happening in Europe, its just sold at high prices in USA as well just like American drug companies do. Just because non Americans makes a drug doesn't make it cheap in USA.

lotsofpulp 2y ago

> Right now the discussion tends to end up with US companies saying they charge so much for new medications to recoup the costs of ideas that didn’t pan out. This is just public relations, because “we want to make as much money as possible” is not good PR. However, everyone wants to make as much money as possible, so faulting pharmaceutical companies for that is stupid. It’s just business. > Since only the drug companies know what didn’t pan out, it’s hard to refute. Lots of pharmaceutical businesses don’t pan out. For every Novo Nordisk, there are a lot of upstart pharma companies that go nowhere and lots of gambling day traders that lose money on the stock. Otherwise, an index of purely pharma companies would be the best performing asset class. > If most drug research happens in the US (and, really, I don’t know if that’s true), then it suggests that the US model does a good job of incentivizing research. If another approach could get the same results, it would refute the drug companies’ argument. Exactly! If it’s so easy to develop medicines, then do it. All these governments around the world are free to invest tens of billions of dollars, and yet none take up the cause.

Jensson 2y ago
> All these governments around the world are free to invest tens of billions of dollars, and yet none take up the cause. It is only expensive in USA, why would anyone else pay to make it cheaper in USA? Until USA changes there is no incentive for anyone else to pay for it. And a very large share of drug research is happening in Europe, its just sold at high prices in USA as well just like American drug companies do. Just because non Americans makes a drug doesn't make it cheap in USA.